Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Aditxt, Inc.

Aditxt, Inc.

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune reprogramming and monitoring.

All edits

Edits on 18 Aug, 2022
Golden AI"Funding autocalculation"
Golden AI edited on 18 Aug, 2022
Edits made to:
Infobox (+3 properties)
Infobox
Latest Funding Round Date
August 17, 2022
Latest Funding Round Amount (USD)
2,200,000
Total Funding Amount (USD)
2,200,000
Golden AI"update inverses"
Golden AI edited on 18 Aug, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI"Entity importer update"
Golden AI edited on 18 Aug, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Full Address
737 N. FIFTH STREET SUITE 200 RICHMOND, VA 23219
Edits on 20 Jul, 2022
Patrick Pum
Patrick Pum edited on 20 Jul, 2022
Edits made to:
Infobox (+7 properties)
Infobox
Location
Exchange
Stock symbol
ADTX
CIK number
IRS number
823,204,328
Place of incorporation
Previous name
ADiTx Therapeutics, Inc.
Aditx Therapeutics, Inc.
SIC code
2,834
Edits on 7 Jul, 2022
Duzenko Andrey
Duzenko Andrey edited on 7 Jul, 2022
Edits made to:
Infobox (+5 properties)
Infobox
Edits on 1 Jun, 2022
Sergey Korchagin
Sergey Korchagin edited on 1 Jun, 2022
Edits made to:
Infobox (+6 properties)
Infobox
Date incorporated
2017
Market capitalization
12,140,000
Stock symbol
ADTX
Edits on 30 May, 2022
N Ni
N Ni edited on 30 May, 2022
Edits made to:
Infobox (+8 properties)
Infobox
Legal name
Aditxt, Inc.
Number of Employees (ranges)
50 – 99
Exchange
Ticker symbol
ADTX
Edits on 27 May, 2022
Olga Drokina"Edit from table cell"
Olga Drokina edited on 27 May, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Company Operating Status
Active
Edits on 17 May, 2022
Katrina-Kay Alaimo"prospector:1525:755133"
Katrina-Kay Alaimo edited on 17 May, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 17 Feb, 2022
N Ni
N Ni edited on 17 Feb, 2022
Edits made to:
Infobox (+3 properties)
Description (+152 characters)
Article (+920 characters)
Topic thumbnail

Aditxt, Inc.

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune reprogramming and monitoring.

Article

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune reprogramming and monitoring. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.

Infobox
N Ni"Created via: Web app"
N Ni created this topic on 17 Feb, 2022
Edits made to:
Infobox (+2 properties)
Topic thumbnail

 Aditxt, Inc.

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune reprogramming and monitoring.

Infobox
Golden logo
By using this site, you agree to our Terms & Conditions.